NEW YORK (GenomeWeb) – Caprion Biosciences said today that it has acquired the assets of ImmuneHealth's immune monitoring laboratory for an undisclosed amount.

Caprion said that it will use the laboratory to "expand its immune monitoring offering and strengthen its business partnerships and research collaborations throughout Europe." The acquisition will also allow Caprion to move into new areas including infectious disease and vaccine development.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.

Sponsored by
Canon BioMedical

This webinar will discuss a project that is analyzing the “Human Brainome” – genome, transcriptome, proteome, and phenome interaction data -- to gain insights into Alzheimer’s disease pathogenesis.